Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3027% below fair value
$1.90+0.04 (+2.15%)
Close on Nov 17, 2026Market cap $382.90MP/E –Yield –
Cerus operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cerus's operating income for the twelve months ending Sep 30, 2026 was -$2.47M. For fiscal 2025 it was -$8.68M. The highest annual figure on record is -$8.68M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.68M | – |
| FY2024 | Dec 31, 2024 | -$14.23M | – |
| FY2023 | Dec 31, 2023 | -$30.05M | – |
| FY2022 | Dec 31, 2022 | -$34.08M | – |
| FY2021 | Dec 31, 2021 | -$48.94M | – |
| FY2020 | Dec 31, 2020 | -$58.33M | – |
| FY2019 | Dec 31, 2019 | -$66.23M | – |
| FY2018 | Dec 31, 2018 | -$54.99M | – |
| FY2017 | Dec 31, 2017 | -$57.53M | – |
| FY2016 | Dec 31, 2016 | -$61.45M | – |
| FY2015 | Dec 31, 2015 | -$61.08M | – |
| FY2014 | Dec 31, 2014 | -$44.50M | – |
| FY2013 | Dec 31, 2013 | -$28.30M | – |
| FY2012 | Dec 31, 2012 | -$17.30M | – |
| FY2011 | Dec 31, 2011 | -$15.92M | – |
| FY2010 | Dec 31, 2010 | -$15.96M | – |
| FY2009 | Dec 31, 2009 | -$23.83M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $383.00K | -69.0% |
| Q2 FY2026 | Jun 30, 2026 | -$1.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$354.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$641.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $1.24M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.42M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.85M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.45M | -248.5% |
| Q3 FY2024 | Sep 30, 2024 | -$961.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.84M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.98M | – |
| Q4 FY2023 | Dec 31, 2023 | $976.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.24M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.64M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.95M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.45M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.85M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.96M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.45M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.34M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.98M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.61M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.40M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.96M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.79M | – |
| Q1 FY2019 | Mar 31, 2019 | -$16.07M | – |
| Q4 FY2018 | Dec 31, 2018 | -$15.46M | – |
| Q3 FY2018 | Sep 30, 2018 | -$13.60M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.57M | – |
| Q1 FY2018 | Mar 31, 2018 | -$13.36M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.85M | – |
| Q3 FY2017 | Sep 30, 2017 | -$12.38M | – |
| Q2 FY2017 | Jun 30, 2017 | -$16.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$18.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.10M | – |
See a number that looks wrong?